"Well that FDA briefing document released Tuesday, worked badly on the shares. Down 45%"
Been watching all this for a long time. Shares dropped yesterday for several reasons, one, the FDA review docs. (which all knew in advance that they would stay negatyive), but sight all info from 2009, so can be refuted by testimony and bt Dr Carter. Two, a negative article by scam artist Adam F at street.com, and three, MM short selling causing stops to be run.
If, and I say if, A gets a majority vote tomorrow, it could be partial, meaning physicians get access, but more studies ongoing at HEB. I do know that HEB has spent lots to prepare for potential ramp in production of both Ampligen and Alferon. I, for one, prasy for Amp approval. I have wanted Amp for 15 years, but no access and cost prohibitive. There are so many like me, 15 yrs diagnosed, 5 years late stage and housebound. None of this means approval will come, but....hoping beyond hope (yes, we all suffer from the hope thing).